PM&R, EarlyView.Abstract Objective To perform a secondary review of low back pain (LBP) clinical practice guidelines (CPG) identified in a recently conducted systematic review and to synthesize and summarize low‐value recommendations as practices that may be candidates for deimplementation.
Daniel Tai +5 more
wiley +1 more source
Treatment of congenital esotropia with botulinum toxin type A [PDF]
Acta Ophthalmologica, 2009 To examine the effect of botulinum toxin type A injections given transconjunctivally into the medial recti muscles in patients with congenital esotropia.Eighty-two patients with congenital esotropia were treated with botulinum toxin type A transconjunctival injections into the medial recti muscles.A Kaplan--Meier curve shows a 24-month success rate of ...
Baggesen, Kirsten +1 more
openaire +4 more sources
Adult‐Onset Dystonia‐Parkinsonism: Do Not Forget SERAC1
Movement Disorders Clinical Practice, EarlyView.
Giulia Scacciatella +15 more
wiley +1 more source
Prevalence of function‐limiting late effects in survivors of head and neck cancer
PM&R, EarlyView.Abstract Background Survivors of head and neck cancer (HNC) are commonly affected by multiple complex and interrelated long‐term and late effects that can adversely affect their function and quality of life. Objective To define the prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality ...
Yu Hui Won, Michael D. Stubblefield
wiley +1 more source
Botulinum toxin-A for the treatment of overactive bladder: UK contributions [PDF]
, 2013 Background: Botulinum toxin-A (BoNT/A) is now established second-line management for refractory overactivebladder (OAB) and recognised in many incontinence guidelines and pathways.
Dasgupta, P +6 more
core +1 more source
Food—Consistency/Texture—Specific Pharyngeal Dystonia: A Novel Form of Focal Task‐Specific Dystonia
Movement Disorders Clinical Practice, EarlyView.
Domenico A. Restivo +5 more
wiley +1 more source
Nectin4‐targeted molecular imaging in solid tumors: Current status and future perspectives
VIEW, EarlyView.In this review, we provide a concise overview of the mechanisms by which Nectin4 contributes to the pathogenesis of various malignancies and detail the classes of Nectin4‐targeted molecular probes. We then delve into the significant advancements in Nectin4‐targeted molecular imaging techniques, encompassing both nuclear medicine and optical imaging ...
Yongshun Liu +6 more
wiley +1 more source
Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial [PDF]
, 2012 Stroke imposes significant burdens on health services and society, and as such there is a growing need to assess the cost-effectiveness of stroke treatment to ensure maximum benefit is derived from limited resources.
Christopher Price +16 more
core +3 more sources
Treatment of dystonias with botulinum toxin Type A [PDF]
Arquivos de Neuro-Psiquiatria, 1995 Botulinum toxin is produced by the anaerobic bacteria Clostridium botulinum. This toxin blocks cholinergic muscle end-plates by means of inhibiting the release of acetylcholine from the pre-synaptic vesicles. Type A botulinum toxin is the most potent of the eight serotypes known to date.
openaire +3 more sources
Clinical Efficacy Analysis of Unilateral Modified Arytenoidectomy for Bilateral Vocal Fold Paralysis
World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.ABSTRACT Purpose To explore the clinical efficacy of unilateral modified arytenoidectomy (UMA) in the treatment of bilateral vocal fold paralysis(BVFP) based on animal models. Methods The UMA which had been tested in excised canine larynges with simulated BVFP was adapted into a clinical technique. The characteristics of this surgical technique involve
Lu Xing, Shu‐Yi Zeng, Pei‐Yun Zhuang
wiley +1 more source